480 related articles for article (PubMed ID: 32805201)
1. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
[TBL] [Abstract][Full Text] [Related]
2. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
[TBL] [Abstract][Full Text] [Related]
5. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
[TBL] [Abstract][Full Text] [Related]
7. Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother.
Wang H; Fang JW; Gu ZW; Song DJ; Chen Y; Chen GD; Zhao B; Sun C; Ma Y; Wang KX; Shen JQ; Yang XF; Luo Q
J Obstet Gynaecol; 2022 Jul; 42(5):877-882. PubMed ID: 34569426
[TBL] [Abstract][Full Text] [Related]
8. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
9. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
[TBL] [Abstract][Full Text] [Related]
10. Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China.
Luo YL; Gao S; Zhang QF; Liu X; Lv DY; Chen JH; Wang W
BMC Public Health; 2024 Jan; 24(1):58. PubMed ID: 38166939
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
[TBL] [Abstract][Full Text] [Related]
12. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
[TBL] [Abstract][Full Text] [Related]
13. Fulminant hepatitis B virus (HBV) infection in an infant following mother-to-child transmission of an e-minus HBV mutant: Time to relook at HBV prophylaxis in South African infants.
Ogunbosi B; Smuts H; Eley B; Korsman S; De Lacy R; Hardie DR
S Afr Med J; 2018 Apr; 108(5):389-392. PubMed ID: 29843851
[TBL] [Abstract][Full Text] [Related]
14. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
15. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases.
Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H
BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230
[TBL] [Abstract][Full Text] [Related]
16. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
[TBL] [Abstract][Full Text] [Related]
18. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
[TBL] [Abstract][Full Text] [Related]
19. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.
Chen T; Wang J; Qiu H; Yu Q; Yan T; Qi C; Cao F; Tian Z; Guo D; Yao N; Yang Y; He Y; Zhao Y; Liu J
Medicine (Baltimore); 2018 Jul; 97(27):e11406. PubMed ID: 29979437
[TBL] [Abstract][Full Text] [Related]
20. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
Ndububa D; Kuti O; Awowole I; Adekanle O; Ijarotimi O; Makinde O; Adeyemi A; Anyabolu C; Ijadunola M
BMJ Open; 2022 Nov; 12(11):e063482. PubMed ID: 36351715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
